140 related articles for article (PubMed ID: 30077613)
1. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis.
Gargalionis AN; Malakou LS; Adamopoulos C; Piperi C; Theohari I; Nokhbehsaim M; Deschner J; Kokkalis G; Korkolopoulou P; Papadavid E; Papavassiliou AG; Basdra EK
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3468-3476. PubMed ID: 30077613
[TBL] [Abstract][Full Text] [Related]
2. Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma.
Gargalionis AN; Sarlani E; Stofas A; Malakou LS; Adamopoulos C; Bamias A; Boutati E; Constantinides CA; Stravodimos KG; Piperi C; Papavassiliou AG; Korkolopoulou P
Cancer Lett; 2020 Oct; 489():135-143. PubMed ID: 32561414
[TBL] [Abstract][Full Text] [Related]
3. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
4. Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.
Papavassiliou KA; Zoi I; Gargalionis AN; Koutsilieris M
J Cell Mol Med; 2019 Sep; 23(9):6215-6227. PubMed ID: 31251475
[TBL] [Abstract][Full Text] [Related]
5. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
[TBL] [Abstract][Full Text] [Related]
6. Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1.
Tang Y; Shi G; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
Biomed Res Int; 2019; 2019():5320747. PubMed ID: 31341901
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model.
Katsianou MA; Papavassiliou KA; Gargalionis AN; Agrogiannis G; Korkolopoulou P; Panagopoulos D; Themistocleous MS; Piperi C; Basdra EK; Papavassiliou AG
J Cell Mol Med; 2022 Apr; 26(8):2428-2437. PubMed ID: 35285136
[TBL] [Abstract][Full Text] [Related]
8. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56
Tang Y; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
Biomed Res Int; 2019; 2019():2582401. PubMed ID: 31641668
[TBL] [Abstract][Full Text] [Related]
9. Polycystins and Mechanotransduction in Human Disease.
Gargalionis AN; Basdra EK; Papavassiliou AG
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052533
[TBL] [Abstract][Full Text] [Related]
10. Polycystin-2 Is Required for Chondrocyte Mechanotransduction and Traffics to the Primary Cilium in Response to Mechanical Stimulation.
Thompson CL; McFie M; Chapple JP; Beales P; Knight MM
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919210
[TBL] [Abstract][Full Text] [Related]
11. Polycystin-1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model.
Katsianou M; Papavassiliou KA; Zoi I; Gargalionis AN; Panagopoulos D; Themistocleous MS; Piperi C; Papavassiliou AG; Basdra EK
J Cell Mol Med; 2021 Apr; 25(7):3216-3225. PubMed ID: 33656806
[TBL] [Abstract][Full Text] [Related]
12. A role for polycystin-1 and polycystin-2 in neural progenitor cell differentiation.
Winokurow N; Schumacher S
Cell Mol Life Sci; 2019 Jul; 76(14):2851-2869. PubMed ID: 30895336
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice.
Tang ZL; Zhang K; Lv SC; Xu GW; Zhang JF; Jia HY
Cytokine; 2021 Dec; 148():155657. PubMed ID: 34425525
[TBL] [Abstract][Full Text] [Related]
14. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
15. Polycystins in Colorectal Cancer.
Gargalionis AN; Basdra EK; Papavassiliou AG
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597875
[TBL] [Abstract][Full Text] [Related]
16. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway.
Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB
J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.
Mekahli D; Decuypere JP; Sammels E; Welkenhuyzen K; Schoeber J; Audrezet MP; Corvelyn A; Dechênes G; Ong AC; Wilmer MJ; van den Heuvel L; Bultynck G; Parys JB; Missiaen L; Levtchenko E; De Smedt H
Pflugers Arch; 2014 Aug; 466(8):1591-604. PubMed ID: 24193408
[TBL] [Abstract][Full Text] [Related]
18. Polycystin and calcium signaling in cell death and survival.
Lemos FO; Ehrlich BE
Cell Calcium; 2018 Jan; 69():37-45. PubMed ID: 28601384
[TBL] [Abstract][Full Text] [Related]
19. Polycystin-1: function as a mechanosensor.
Dalagiorgou G; Basdra EK; Papavassiliou AG
Int J Biochem Cell Biol; 2010 Oct; 42(10):1610-3. PubMed ID: 20601082
[TBL] [Abstract][Full Text] [Related]
20. Polycystin-1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro.
Zoi I; Gargalionis AN; Papavassiliou KA; Nasiri-Ansari N; Piperi C; Basdra EK; Papavassiliou AG
J Cell Mol Med; 2022 Mar; 26(5):1699-1709. PubMed ID: 35106909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
